Literature DB >> 22025616

Mimicry of the regulatory role of urokinase in lamellipodia formation by introduction of a non-native interdomain disulfide bond in its receptor.

Henrik Gårdsvoll1, Magnus Kjaergaard, Benedikte Jacobsen, Mette C Kriegbaum, Mingdong Huang, Michael Ploug.   

Abstract

The high-affinity interaction between the urokinase-type plasminogen activator (uPA) and its glycolipid-anchored receptor (uPAR) plays a regulatory role for both extravascular fibrinolysis and uPAR-mediated adhesion and migration on vitronectin-coated surfaces. We have recently proposed that the adhesive function of uPAR is allosterically regulated via a "tightening" of its three-domain structure elicited by uPA binding. To challenge this proposition, we redesigned the uPAR structure to limit its inherent conformational flexibility by covalently tethering domains DI and DIII via a non-natural interdomain disulfide bond (uPAR(H47C-N259C)). The corresponding soluble receptor has 1) a smaller hydrodynamic volume, 2) a higher content of secondary structure, and 3) unaltered binding kinetics towards uPA. Most importantly, the purified uPAR(H47C-N259C) also displays a gain in affinity for the somatomedin B domain of vitronectin compared with uPAR(wt), thus recapitulating the improved affinity that accompanies uPA-uPAR(wt) complex formation. This functional mimicry is, intriguingly, operational also in a cellular setting, where it controls lamellipodia formation in uPAR-transfected HEK293 cells adhering to vitronectin. In this respect, the engineered constraint in uPAR(H47C-N259C) thus bypasses the regulatory role of uPA binding, resulting in a constitutively active uPAR. In conclusion, our data argue for a biological relevance of the interdomain dynamics of the glycolipid-anchored uPAR on the cell surface.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22025616      PMCID: PMC3234840          DOI: 10.1074/jbc.M111.300020

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  50 in total

1.  Structure of human urokinase plasminogen activator in complex with its receptor.

Authors:  Qing Huai; Andrew P Mazar; Alice Kuo; Graham C Parry; David E Shaw; Jennifer Callahan; Yongdong Li; Cai Yuan; Chuanbing Bian; Liqing Chen; Bruce Furie; Barbara C Furie; Douglas B Cines; Mingdong Huang
Journal:  Science       Date:  2006-02-03       Impact factor: 47.728

2.  One-step affinity purification of recombinant urokinase-type plasminogen activator receptor using a synthetic peptide developed by combinatorial chemistry.

Authors:  Benedikte Jacobsen; Henrik Gårdsvoll; Gitte Juhl Funch; Søren Ostergaard; Vibeke Barkholt; Michael Ploug
Journal:  Protein Expr Purif       Date:  2006-08-30       Impact factor: 1.650

3.  Amino acid neighbours and detailed conformational analysis of cysteines in proteins.

Authors:  M T Petersen; P H Jonson; S B Petersen
Journal:  Protein Eng       Date:  1999-07

4.  Mapping of the vitronectin-binding site on the urokinase receptor: involvement of a coherent receptor interface consisting of residues from both domain I and the flanking interdomain linker region.

Authors:  Henrik Gårdsvoll; Michael Ploug
Journal:  J Biol Chem       Date:  2007-03-13       Impact factor: 5.157

5.  Characterization of the functional epitope on the urokinase receptor. Complete alanine scanning mutagenesis supplemented by chemical cross-linking.

Authors:  Henrik Gårdsvoll; Bernard Gilquin; Marie Hélène Le Du; Andre Ménèz; Thomas J D Jørgensen; Michael Ploug
Journal:  J Biol Chem       Date:  2006-05-03       Impact factor: 5.157

6.  An uncleavable uPAR mutant allows dissection of signaling pathways in uPA-dependent cell migration.

Authors:  Roberta Mazzieri; Silvia D'Alessio; Richard Kamgang Kenmoe; Liliana Ossowski; Francesco Blasi
Journal:  Mol Biol Cell       Date:  2005-11-02       Impact factor: 4.138

7.  Stromal cells associated with early invasive foci in human mammary ductal carcinoma in situ coexpress urokinase and urokinase receptor.

Authors:  Boye S Nielsen; Fritz Rank; Martin Illemann; Leif R Lund; Keld Danø
Journal:  Int J Cancer       Date:  2007-05-15       Impact factor: 7.396

8.  Murine monoclonal antibodies against murine uPA receptor produced in gene-deficient mice: inhibitory effects on receptor-mediated uPA activity in vitro and in vivo.

Authors:  Jesper Pass; Annika Jögi; Ida K Lund; Birgitte Rønø; Morten G Rasch; Henrik Gårdsvoll; Leif R Lund; Michael Ploug; John Rømer; Keld Danø; Gunilla Høyer-Hansen
Journal:  Thromb Haemost       Date:  2007-06       Impact factor: 5.249

9.  Regulation of alpha5beta1 integrin conformation and function by urokinase receptor binding.

Authors:  Ying Wei; Ralf-Peter Czekay; Liliane Robillard; Matthias C Kugler; Feng Zhang; Kevin K Kim; Jian-Ping Xiong; Martin J Humphries; Harold A Chapman
Journal:  J Cell Biol       Date:  2005-01-31       Impact factor: 10.539

10.  uPAR-induced cell adhesion and migration: vitronectin provides the key.

Authors:  Chris D Madsen; Gian Maria Sarra Ferraris; Annapaola Andolfo; Orla Cunningham; Nicolai Sidenius
Journal:  J Cell Biol       Date:  2007-06-04       Impact factor: 10.539

View more
  14 in total

1.  The urokinase receptor homolog Haldisin is a novel differentiation marker of stratum granulosum in squamous epithelia.

Authors:  Henrik Gårdsvoll; Mette C Kriegbaum; Emil P Hertz; Warner Alpízar-Alpízar; Michael Ploug
Journal:  J Histochem Cytochem       Date:  2013-07-29       Impact factor: 2.479

2.  Did evolution create a flexible ligand-binding cavity in the urokinase receptor through deletion of a plesiotypic disulfide bond?

Authors:  Julie M Leth; Haydyn D T Mertens; Katrine Zinck Leth-Espensen; Thomas J D Jørgensen; Michael Ploug
Journal:  J Biol Chem       Date:  2019-03-20       Impact factor: 5.157

3.  Probing binding and cellular activity of pyrrolidinone and piperidinone small molecules targeting the urokinase receptor.

Authors:  Timmy Mani; Degang Liu; Donghui Zhou; Liwei Li; William Eric Knabe; Fang Wang; Kyungsoo Oh; Samy O Meroueh
Journal:  ChemMedChem       Date:  2013-10-02       Impact factor: 3.466

4.  Re-engineering the Immune Response to Metastatic Cancer: Antibody-Recruiting Small Molecules Targeting the Urokinase Receptor.

Authors:  Anthony F Rullo; Kelly J Fitzgerald; Viswanathan Muthusamy; Min Liu; Cai Yuan; Mingdong Huang; Minsup Kim; Art E Cho; David A Spiegel
Journal:  Angew Chem Int Ed Engl       Date:  2016-02-16       Impact factor: 15.336

5.  Administration of recombinant soluble urokinase receptor per se is not sufficient to induce podocyte alterations and proteinuria in mice.

Authors:  Dominique Cathelin; Sandrine Placier; Michael Ploug; Marie-Christine Verpont; Sophie Vandermeersch; Yosu Luque; Alexandre Hertig; Eric Rondeau; Laurent Mesnard
Journal:  J Am Soc Nephrol       Date:  2014-05-01       Impact factor: 10.121

6.  A flexible multidomain structure drives the function of the urokinase-type plasminogen activator receptor (uPAR).

Authors:  Haydyn D T Mertens; Magnus Kjaergaard; Simon Mysling; Henrik Gårdsvoll; Thomas J D Jørgensen; Dmitri I Svergun; Michael Ploug
Journal:  J Biol Chem       Date:  2012-08-15       Impact factor: 5.157

7.  A new class of orthosteric uPAR·uPA small-molecule antagonists are allosteric inhibitors of the uPAR·vitronectin interaction.

Authors:  Degang Liu; Donghui Zhou; Bo Wang; William Eric Knabe; Samy O Meroueh
Journal:  ACS Chem Biol       Date:  2015-03-31       Impact factor: 5.100

8.  Single amino acid substitutions in the chemotactic sequence of urokinase receptor modulate cell migration and invasion.

Authors:  Katia Bifulco; Immacolata Longanesi-Cattani; Paola Franco; Vincenzo Pavone; Pietro Mugione; Gioconda Di Carluccio; Maria Teresa Masucci; Claudio Arra; Giuseppe Pirozzi; Maria Patrizia Stoppelli; Maria Vincenza Carriero
Journal:  PLoS One       Date:  2012-09-25       Impact factor: 3.240

9.  Mapping the topographic epitope landscape on the urokinase plasminogen activator receptor (uPAR) by surface plasmon resonance and X-ray crystallography.

Authors:  Baoyu Zhao; Sonu Gandhi; Cai Yuan; Zhipu Luo; Rui Li; Henrik Gårdsvoll; Valentina de Lorenzi; Nicolai Sidenius; Mingdong Huang; Michael Ploug
Journal:  Data Brief       Date:  2015-09-04

Review 10.  Structure-driven design of radionuclide tracers for non-invasive imaging of uPAR and targeted radiotherapy. The tale of a synthetic peptide antagonist.

Authors:  Michael Ploug
Journal:  Theranostics       Date:  2013-06-24       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.